Gautam Mukunda, writing for Bloomberg on September 17, 2026, argues that current voluntary biosecurity guidelines are insufficient to manage risks posed by artificial intelligence. He proposes making the screening of all synthesized DNA orders mandatory.
A study led by Microsoft in October 2025 revealed that AI-generated protein variants can evade commercial screening tools. Detection rates for these sequences dropped to 32%, allowing approximately two-thirds of dangerous designs to pass undetected.
In June 2026, leaders from major AI firms, including Sam Altman of OpenAI and Demis Hassabis of Google DeepMind, signed an open letter calling on Congress to tighten regulations for DNA and RNA synthesis.
Legislative efforts are underway with the introduction of the Biosecurity Modernization and Innovation Act of 2026. This act aims to address the limitations of the existing voluntary framework for biosecurity.
Research indicates that 70% of national security professionals believe AI significantly increases the threat of biological weapons. Experts argue that screening databases must evolve to keep pace with AI capabilities.
